Crossmark

Effect of cyclophospamide, doxorubicin, vincristine and prednisone/prednisolone (CHOP) chemotherapy regimens on left ventricular systolic function and cardiac structural abnormalities in non-Hodgkin lymphoma patients

Crossref DOI link: https://doi.org/10.1186/s43046-025-00288-w

Published Online: 2025-05-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Septianda, Imanita

Alsagaff, Mochamad Yusuf

Pikir, Budi Susetyo

Ashariati, Ami

Fuadi, Muhamad Robiul

Zahra, Fatimah
License Information

Text and Data Mining valid from 2025-05-01

Version of Record valid from 2025-05-01
More Information

Article History

Received: 2 January 2025

Accepted: 12 April 2025

First Online: 1 May 2025

Declarations

:

: This study was approved by the Research Ethics Committee of Dr. Soetomo General Hospital, with author MYA as the principal investigator (protocol number: 0685/KEPK/VI/2023). The 2016 WHO-CIOMS revised guidelines serve as a reference for ethical reviews, ensuring research involving human subjects complies with the Helsinki Declaration. All participants provided written informed consent, ensuring confidentiality and the exclusion of personally identifiable information. The study’s objectives, design, methods, advantages, and disadvantages were all described in the consent form. Confidentiality and anonymity were rigorously upheld.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below